RNAC icon

Cartesian Therapeutics
RNAC

Overview Fund Activity

53 hedge funds and large institutions have $222M invested in Cartesian Therapeutics in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+5
Holders Change %
+10.42%
% of All Funds
1.32%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
8
Increased
24
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PA
Perceptive Advisors
New York
$21.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
$9.43M
3
OM
Opaleye Management
Massachusetts
$1.73M
4
BlackRock
BlackRock
New York
$10.6M
5
Two Sigma Investments
Two Sigma Investments
New York
$951K

Top Sellers

1
PVMCV
Polaris Venture Management Co V
Massachusetts
$29.7M
2
Millennium Management
Millennium Management
New York
$1.15M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
$0
4
DM
Deerfield Management
New York
$17.4M
5
GPP
Great Point Partners
Connecticut
$16.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
AIP
51
Ameritas Investment Partners
Nebraska
$18K – – –
Bank of America
52
Bank of America
North Carolina
$12K +$11.5K +21 +2,100%
SIA
53
SeaBridge Investment Advisors
New Jersey
$2K – – –
Point72 Asset Management
54
Point72 Asset Management
Connecticut
– -$2.38M -3,995 Closed
PHK
55
Point72 Hong Kong
Hong Kong
– -$4K -6 Closed
Citigroup
56
Citigroup
New York
– -$3K -4 Closed
1 2
3